TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) EGX:RMDA:
Q3 NET INCOME EGP 96 MILLION
Q3 REVENUE EGP 1.14 BILLION
Egypt's Rameda Q3 Income EGP 96 Mln
Earlier from Tenth Of Ramadan Pharmaceutical Industries & Diagnostic-rameda
- Egypt's Rameda Borad Proposes To Increase Issued Capital
- SNG: Egypt: Rameda reports 44.3% YoY consolidated profit decline in Q1 2025
- Egypt's Rameda Reports Q1 Profit EGP 85.9 Mln
- SNG: Egypt: Rameda to pay $3.15mln cash dividends for 2024